524742 Stock Overview
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Price-To-Earnings ratio (15.9x) is below the Indian market (22.3x)
Risk Analysis
No risks detected for 524742 from our risk checks.
My Notes
NewNotes are coming soon
Caplin Point Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹692.45 |
| 52 Week High | ₹856.00 |
| 52 Week Low | ₹626.30 |
| Beta | 0.41 |
| 1 Month Change | -4.27% |
| 3 Month Change | -5.83% |
| 1 Year Change | -16.16% |
| 3 Year Change | 112.47% |
| 5 Year Change | 17.25% |
| Change since IPO | 314,650.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524742 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.6% | -1.8% | -3.7% |
| 1Y | -16.2% | -7.6% | -2.2% |
Return vs Industry: 524742 underperformed the Indian Pharmaceuticals industry which returned -7.6% over the past year.
Return vs Market: 524742 underperformed the Indian Market which returned -2.2% over the past year.
Price Volatility
| 524742 volatility | |
|---|---|
| 524742 Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.3% |
Stable Share Price: 524742 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 524742's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 3,000 | Sridhar Ganesan | https://www.caplinpoint.net |
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic droppers, prefilled bags, tablets, dry syrups, soft gels, capsules, suppositories, liquid syrups in bottles, liquid injectables in ampoules and vials, prefilled syringes, emulsion injection in ampoules and vials, topicals, and sachets. It also operates QueTenX, an e-commerce website.
Caplin Point Laboratories Limited Fundamentals Summary
| 524742 fundamental statistics | |
|---|---|
| Market Cap | ₹52.49b |
| Earnings (TTM) | ₹3.31b |
| Revenue (TTM) | ₹13.72b |
15.9x
P/E Ratio3.8x
P/S RatioIs 524742 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524742 income statement (TTM) | |
|---|---|
| Revenue | ₹13.72b |
| Cost of Revenue | ₹6.33b |
| Gross Profit | ₹7.39b |
| Other Expenses | ₹4.08b |
| Earnings | ₹3.31b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 11, 2023
| Earnings per share (EPS) | 43.57 |
| Gross Margin | 53.85% |
| Net Profit Margin | 24.10% |
| Debt/Equity Ratio | 0.01% |
How did 524742 perform over the long term?
See historical performance and comparison